Literature DB >> 9351986

Chronic subdural haematoma--a comparison of two different treatment modalities.

C Smely1, A Madlinger, R Scheremet.   

Abstract

Burr-hole craniotomy (BHC) and closed-system drainage undoubtedly is currently the most accepted treatment offered in chronic subdural haematoma (CSDH). Although twist-drill trephination (TDT) techniques have been available for years, now a special subdural catheter kit has been launched for treatment of CSDH. In a prospective study, 33 patients with 36 CSDH were treated with a 5-mm TDT regimen and insertion of a CORDIS subdural catheter (CORDIS Corp., Miami, USA). The results are compared with a consecutive series of 33 patients treated previously with an 11-mm BHC and closed-system drainage for 40 CSDH: Recurrence and persistence rate of CSDH treated with TDT necessitating a second intervention was 18.1%, no further surgical intervention was necessary. In BHC treated patients, 33.3% of haematomas had to be reoperated on, another 6.0% had to be re-operated on a third time. Infection rate in BHC treated patients was 18.1% as compared with a 0% infection rate in patients treated with the TDT technique. Mortality rate for the BHC method was 9.0% as compared with 6.0% in the TDT treatment regimen. Significantly better clinical results are achieved using the TDT technique with insertion of a special subdural catheter, making this procedure superior to the BHC regimen.

Entities:  

Mesh:

Year:  1997        PMID: 9351986     DOI: 10.1007/bf01411399

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  23 in total

Review 1.  Chronic subdural haematoma in the elderly.

Authors:  V Adhiyaman; M Asghar; K N Ganeshram; B K Bhowmick
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

2.  Outcome of contemporary surgery for chronic subdural haematoma: evidence based review.

Authors:  R Weigel; P Schmiedek; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

Review 3.  Membranectomy in Chronic Subdural Hematoma: Meta-Analysis.

Authors:  Ronald Sahyouni; Hossein Mahboubi; Peter Tran; John S Roufail; Jefferson W Chen
Journal:  World Neurosurg       Date:  2017-05-13       Impact factor: 2.104

4.  Twist-Drill or Burr Hole Craniostomy for Draining Chronic Subdural Hematomas: How to Choose It for Chronic Subdural Hematoma Drainage.

Authors:  Seong-Jong Lee; Sun-Chul Hwang; Soo Bin Im
Journal:  Korean J Neurotrauma       Date:  2016-10-31

Review 5.  The surgical management of chronic subdural hematoma.

Authors:  Andrew F Ducruet; Bartosz T Grobelny; Brad E Zacharia; Zachary L Hickman; Peter L DeRosa; Kristen N Andersen; Kristen Anderson; Eric Sussman; Austin Carpenter; E Sander Connolly
Journal:  Neurosurg Rev       Date:  2011-09-10       Impact factor: 3.042

6.  Prospective analysis of bedside percutaneous subdural tapping for the treatment of chronic subdural haematoma in adults.

Authors:  M H Reinges; I Hasselberg; V Rohde; W Küker; J M Gilsbach
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

7.  Benefits of the Subdural Evacuating Port System (SEPS) Procedure Over Traditional Craniotomy for Subdural Hematoma Evacuation.

Authors:  Danielle Golub; Kimberly Ashayeri; Siddhant Dogra; Ariane Lewis; Donato Pacione
Journal:  Neurohospitalist       Date:  2020-05-04

8.  Tension pneumocephalus as complication of burr-hole drainage of chronic subdural hematoma: A case report.

Authors:  Nissar Shaikh; Irfan Masood; Yolande Hanssens; André Louon; Abdel Hafiz
Journal:  Surg Neurol Int       Date:  2010-07-06

Review 9.  Management of Subdural Hematomas: Part II. Surgical Management of Subdural Hematomas.

Authors:  Elena I Fomchenko; Emily J Gilmore; Charles C Matouk; Jason L Gerrard; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2018-07-18       Impact factor: 3.598

Review 10.  Chronic subdural haematoma: modern management and emerging therapies.

Authors:  Angelos G Kolias; Aswin Chari; Thomas Santarius; Peter J Hutchinson
Journal:  Nat Rev Neurol       Date:  2014-09-16       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.